MR vs. FFR in Non-Culprit Lesions

Magnetic resonance (MR) and fractional flow reserve (FFR) correlate moderately as regards the assessment of non-culprit lesions in patients admitted with acute myocardial infarction who underwent primary angioplasty. For a similar degree of diagnostic accuracy, we would require a visual, semiquantitative, or fully quantitative comprehensive assessment of lesions.

Resonancia vs FFR en lesiones no culpables del infarto

This work, soon to be published in J Am Coll Cardiol Img, looked into the degree of correlation between FFR and MR in the assessment of non-culprit lesions after an infarction.

The study included 77 patients who underwent primary angioplasty and had at least one non-culprit lesion with intermediate stenosis (between 70% and 90%). All patients were assessed through FFR and MR one month after infarction. The MR protocol included stress and rest perfusion, cine imaging, and late gadolinium enhancement. Fully quantitative, semiquantitative, and visual analysis of myocardial perfusion were compared against a reference FFR.


Read also: Predilation in TAVR: Definitive Data for Easier Decision-Making?


Visual analysis through MR displayed an area under the curve of 0.74, with a sensitivity of 73% and a specificity of 70%. The semiquantitative analysis had results similar to those derived from the visual analysis. The MR myocardial blood flow was slightly better than the other parameters, but it still was far from perfect (an area under the curve of 0.82, with a sensitivity of 82% and a specificity of 71%).

Conclusion

Cardiac magnetic resonance and invasive fractional flow reserve have a moderately good correlation as regards non-culprit lesions in patients who suffered from an acute myocardial infarction. All MR parameters yielded a similar diagnostic performance and do not seem enough to replace FFR.

Original Title: Cardiac Magnetic Resonance for Evaluating Nonculprit Lesions After Myocardial Infarction Comparison With Fractional Flow Reserve.

Reference: Henk Everaars et al. J Am Coll Cardiol Img 2020, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...